Perspectives from ASMS 69: Part I

 Perspectives from ASMS 69: Part I

by Dr. Robert L. Stevenson

Due to COVID-19, ASMS 2021 was held as a virtual/in-person hybrid meeting. ASMS 69 needed a virtual component since travel to the U.S. was still restricted. Depending on country of origin, those outside the U.S. could face a multi-week quarantine upon returning home. New Zealand, for example, was set to impose a two-week quarantine for potential returning residents.

COVID-19 caused delays in many development programs due to shutdown of R&D facilities. I was interested in the impact on product and applications development—the loss was much less than I’d expected. For example, the staff at Bruker apparently used the shutdown to catch up on writing—they were listed as authors on 48 posters. My sampling shows the quality is very good.

Read more on Labcompare.